APO Research

APO RESEARCH · REPORT

Over-the-Counter Drugs

Selected research

Industry Growth & Trends

Global Over-the-Counter Drugs Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Over-the-Counter Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Over-the-Counter Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Over-the-Counter Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Over-the-Counter Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Over-the-Counter Drugs market include Teva Pharmaceutical Industries, Sanofi, Johnson & Johnson, Novartis, Merck, Pfizer, GlaxoSmithKline, Bayer and Sun Pharmaceutical Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Over-the-Counter Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Over-the-Counter Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Over-the-Counter Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Over-the-Counter Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Over-the-Counter Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Over-the-Counter Drugs Market by Company

Teva Pharmaceutical Industries

Sanofi

Johnson & Johnson

Novartis

Merck

Pfizer

GlaxoSmithKline

Bayer

Sun Pharmaceutical Industries

Glenmark Pharmaceuticals

Cipla

Boehringer Ingelheim

Alkem Laboratories

Over-the-Counter Drugs Segment by Type

Cough, Cold and Flu Products

Weight Loss Products

Smoking Cession Aids

Dermatological Products

Sleep Aids

Vitamin & Mineral Supplements

Gastrointestinal Products

Ophthalmic Products

Analgesics & Pain Relievers

Other

Over-the-Counter Drugs Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Over-the-Counter Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Over-the-Counter Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Over-the-Counter Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Over-the-Counter Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Over-the-Counter Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Over-the-Counter Drugs Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Over-the-Counter Drugs Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Over-the-Counter Drugs Market Share by Region (2021-2026) Table 4. Global Over-the-Counter Drugs Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Over-the-Counter Drugs Market Share by Region (2027-2032) Table 6. Global Over-the-Counter Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Over-the-Counter Drugs Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Over-the-Counter Drugs Market Size Share by Type (2021-2026) Table 9. Global Over-the-Counter Drugs Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Over-the-Counter Drugs Market Size Share Forecasted by Type (2027-2032) Table 11. North America Over-the-Counter Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Over-the-Counter Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Over-the-Counter Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Over-the-Counter Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Over-the-Counter Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Over-the-Counter Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Over-the-Counter Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Over-the-Counter Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Over-the-Counter Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Over-the-Counter Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Over-the-Counter Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Over-the-Counter Drugs Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Over-the-Counter Drugs Market Size Share by Application (2021-2026) Table 24. Global Over-the-Counter Drugs Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Over-the-Counter Drugs Market Size Share Forecasted by Application (2027-2032) Table 26. North America Over-the-Counter Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Over-the-Counter Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Over-the-Counter Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Over-the-Counter Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Over-the-Counter Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Over-the-Counter Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Over-the-Counter Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Over-the-Counter Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Over-the-Counter Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Over-the-Counter Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Over-the-Counter Drugs Industry Trends Table 37. Over-the-Counter Drugs Industry Drivers Table 38. Over-the-Counter Drugs Industry Opportunities and Challenges Table 39. Over-the-Counter Drugs Industry Restraints Table 40. Global Over-the-Counter Drugs Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Over-the-Counter Drugs Revenue Market Share by Company (2021-2026) Table 42. Global Over-the-Counter Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Over-the-Counter Drugs Key Company Headquarters & Area Served Table 44. Global Over-the-Counter Drugs Company, Product Type & Application Table 45. Global Over-the-Counter Drugs Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Over-the-Counter Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Teva Pharmaceutical Industries Company Information Table 49. Teva Pharmaceutical Industries Business Overview Table 50. Teva Pharmaceutical Industries Over-the-Counter Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Teva Pharmaceutical Industries Over-the-Counter Drugs Product Portfolio Table 52. Teva Pharmaceutical Industries Recent Development Table 53. Sanofi Company Information Table 54. Sanofi Business Overview Table 55. Sanofi Over-the-Counter Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Sanofi Over-the-Counter Drugs Product Portfolio Table 57. Sanofi Recent Development Table 58. Johnson & Johnson Company Information Table 59. Johnson & Johnson Business Overview Table 60. Johnson & Johnson Over-the-Counter Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Johnson & Johnson Over-the-Counter Drugs Product Portfolio Table 62. Johnson & Johnson Recent Development Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis Over-the-Counter Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Novartis Over-the-Counter Drugs Product Portfolio Table 67. Novartis Recent Development Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck Over-the-Counter Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Merck Over-the-Counter Drugs Product Portfolio Table 72. Merck Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Over-the-Counter Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Pfizer Over-the-Counter Drugs Product Portfolio Table 77. Pfizer Recent Development Table 78. GlaxoSmithKline Company Information Table 79. GlaxoSmithKline Business Overview Table 80. GlaxoSmithKline Over-the-Counter Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. GlaxoSmithKline Over-the-Counter Drugs Product Portfolio Table 82. GlaxoSmithKline Recent Development Table 83. Bayer Company Information Table 84. Bayer Business Overview Table 85. Bayer Over-the-Counter Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Bayer Over-the-Counter Drugs Product Portfolio Table 87. Bayer Recent Development Table 88. Sun Pharmaceutical Industries Company Information Table 89. Sun Pharmaceutical Industries Business Overview Table 90. Sun Pharmaceutical Industries Over-the-Counter Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Sun Pharmaceutical Industries Over-the-Counter Drugs Product Portfolio Table 92. Sun Pharmaceutical Industries Recent Development Table 93. Glenmark Pharmaceuticals Company Information Table 94. Glenmark Pharmaceuticals Business Overview Table 95. Glenmark Pharmaceuticals Over-the-Counter Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Glenmark Pharmaceuticals Over-the-Counter Drugs Product Portfolio Table 97. Glenmark Pharmaceuticals Recent Development Table 98. Cipla Company Information Table 99. Cipla Business Overview Table 100. Cipla Over-the-Counter Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Cipla Over-the-Counter Drugs Product Portfolio Table 102. Cipla Recent Development Table 103. Boehringer Ingelheim Company Information Table 104. Boehringer Ingelheim Business Overview Table 105. Boehringer Ingelheim Over-the-Counter Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Boehringer Ingelheim Over-the-Counter Drugs Product Portfolio Table 107. Boehringer Ingelheim Recent Development Table 108. Alkem Laboratories Company Information Table 109. Alkem Laboratories Business Overview Table 110. Alkem Laboratories Over-the-Counter Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Alkem Laboratories Over-the-Counter Drugs Product Portfolio Table 112. Alkem Laboratories Recent Development Table 113. North America Over-the-Counter Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Over-the-Counter Drugs Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Over-the-Counter Drugs Market Share by Country (2021-2026) Table 116. North America Over-the-Counter Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Over-the-Counter Drugs Market Share Forecast by Country (2027-2032) Table 118. Europe Over-the-Counter Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Over-the-Counter Drugs Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Over-the-Counter Drugs Market Share by Country (2021-2026) Table 121. Europe Over-the-Counter Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Over-the-Counter Drugs Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Over-the-Counter Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Over-the-Counter Drugs Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Over-the-Counter Drugs Market Share by Country (2021-2026) Table 126. Asia-Pacific Over-the-Counter Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Over-the-Counter Drugs Market Share Forecast by Country (2027-2032) Table 128. Latin America Over-the-Counter Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Latin America Over-the-Counter Drugs Market Size by Country (2021-2026) & (US$ Million) Table 130. Latin America Over-the-Counter Drugs Market Share by Country (2021-2026) Table 131. Latin America Over-the-Counter Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Latin America Over-the-Counter Drugs Market Share Forecast by Country (2027-2032) Table 133. Middle East & Africa Over-the-Counter Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Middle East & Africa Over-the-Counter Drugs Market Size by Country (2021-2026) & (US$ Million) Table 135. Middle East & Africa Over-the-Counter Drugs Market Share by Country (2021-2026) Table 136. Middle East & Africa Over-the-Counter Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Middle East & Africa Over-the-Counter Drugs Market Share Forecast by Country (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Over-the-Counter Drugs Product Image Figure 3. Global Over-the-Counter Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Over-the-Counter Drugs Market Size (2021-2032) & (US$ Million) Figure 5. Global Over-the-Counter Drugs Market Share by Region: 2025 VS 2032 Figure 6. Global Over-the-Counter Drugs Market Share by Region (2021-2032) Figure 7. North America Over-the-Counter Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Over-the-Counter Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Over-the-Counter Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Over-the-Counter Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Over-the-Counter Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Cough, Cold and Flu Products Image Figure 13. Global Cough, Cold and Flu Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Weight Loss Products Image Figure 15. Global Weight Loss Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Smoking Cession Aids Image Figure 17. Global Smoking Cession Aids Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Dermatological Products Image Figure 19. Global Dermatological Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Sleep Aids Image Figure 21. Global Sleep Aids Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Vitamin & Mineral Supplements Image Figure 23. Global Vitamin & Mineral Supplements Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Gastrointestinal Products Image Figure 25. Global Gastrointestinal Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Ophthalmic Products Image Figure 27. Global Ophthalmic Products Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Analgesics & Pain Relievers Image Figure 29. Global Analgesics & Pain Relievers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. Other Image Figure 31. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Global Over-the-Counter Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 33. Global Over-the-Counter Drugs Market Share by Type 2025 VS 2032 Figure 34. North America Over-the-Counter Drugs Market Size Share by Type (2021-2032) Figure 35. Europe Over-the-Counter Drugs Market Size Share by Type (2021-2032) Figure 36. Asia-Pacific Over-the-Counter Drugs Market Size Share by Type (2021-2032) Figure 37. Latin America Over-the-Counter Drugs Market Size Share by Type (2021-2032) Figure 38. Middle East and Africa Over-the-Counter Drugs Market Size Share by Type (2021-2032) Figure 39. Hospital Pharmacies Image Figure 40. Global Hospital Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Online Pharmacies Image Figure 42. Global Online Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. Retail Pharmacies Image Figure 44. Global Retail Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Global Over-the-Counter Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 46. Global Over-the-Counter Drugs Market Share by Application 2025 VS 2032 Figure 47. North America Over-the-Counter Drugs Market Size Share by Application (2021-2032) Figure 48. Europe Over-the-Counter Drugs Market Size Share by Application (2021-2032) Figure 49. Asia-Pacific Over-the-Counter Drugs Market Size Share by Application (2021-2032) Figure 50. Latin America Over-the-Counter Drugs Market Size Share by Application (2021-2032) Figure 51. Middle East and Africa Over-the-Counter Drugs Market Size Share by Application (2021-2032) Figure 52. Global Top 5 and 10 Over-the-Counter Drugs Players Market Share by Revenue in 2025 Figure 53. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 54. North America Over-the-Counter Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. North America Over-the-Counter Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. North America Over-the-Counter Drugs Market Share by Country (2021-2032) Figure 57. Europe Over-the-Counter Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Over-the-Counter Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Over-the-Counter Drugs Market Share by Country (2021-2032) Figure 60. Asia-Pacific Over-the-Counter Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Asia-Pacific Over-the-Counter Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Over-the-Counter Drugs Market Share by Country (2021-2032) Figure 63. Latin America Over-the-Counter Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Over-the-Counter Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Over-the-Counter Drugs Market Share by Country (2021-2032) Figure 66. Middle East & Africa Over-the-Counter Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 67. Middle East & Africa Over-the-Counter Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 68. Middle East & Africa Over-the-Counter Drugs Market Share by Country (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Cough, Cold and Flu Products
  • Weight Loss Products
  • Smoking Cession Aids
  • Dermatological Products
  • Sleep Aids
  • Vitamin & Mineral Supplements
  • Gastrointestinal Products
  • Ophthalmic Products
  • Analgesics & Pain Relievers
  • Other
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Teva Pharmaceutical Industries
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • Sun Pharmaceutical Industries
  • Glenmark Pharmaceuticals
  • Cipla
  • Boehringer Ingelheim
  • Alkem Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Over-the-Counter Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Over-the-Counter Drugs Market Size by Region (2021-2032)
  5. 1.4.1 Global Over-the-Counter Drugs Market Size by Region (2021-2026)
  6. 1.4.2 Global Over-the-Counter Drugs Market Size by Region (2027-2032)
  7. 1.5 Key Regions Over-the-Counter Drugs Market Size (2021-2032)
  8. 1.5.1 North America Over-the-Counter Drugs Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Over-the-Counter Drugs Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Over-the-Counter Drugs Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Over-the-Counter Drugs Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Over-the-Counter Drugs Market Size Growth Rate (2021-2032)
2 Over-the-Counter Drugs Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Cough, Cold and Flu Products
  3. 2.1.2 Weight Loss Products
  4. 2.1.3 Smoking Cession Aids
  5. 2.1.4 Dermatological Products
  6. 2.1.5 Sleep Aids
  7. 2.1.6 Vitamin & Mineral Supplements
  8. 2.1.7 Gastrointestinal Products
  9. 2.1.8 Ophthalmic Products
  10. 2.1.9 Analgesics & Pain Relievers
  11. 2.1.10 Other
  12. 2.2 Global Over-the-Counter Drugs Market Size by Type
  13. 2.2.1 Global Over-the-Counter Drugs Market Size Overview by Type (2021-2032)
  14. 2.2.2 Global Over-the-Counter Drugs Historic Market Size Review by Type (2021-2026)
  15. 2.2.3 Global Over-the-Counter Drugs Market Size Forecasted by Type (2027-2032)
  16. 2.3 Global Over-the-Counter Drugs Market Size by Regions
  17. 2.3.1 North America Over-the-Counter Drugs Market Size Breakdown by Type (2021-2026)
  18. 2.3.2 Europe Over-the-Counter Drugs Market Size Breakdown by Type (2021-2026)
  19. 2.3.3 Asia-Pacific Over-the-Counter Drugs Market Size Breakdown by Type (2021-2026)
  20. 2.3.4 South America Over-the-Counter Drugs Market Size Breakdown by Type (2021-2026)
  21. 2.3.5 Middle East and Africa Over-the-Counter Drugs Market Size Breakdown by Type (2021-2026)
3 Over-the-Counter Drugs Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital Pharmacies
  3. 3.1.2 Online Pharmacies
  4. 3.1.3 Retail Pharmacies
  5. 3.2 Global Over-the-Counter Drugs Market Size by Application
  6. 3.2.1 Global Over-the-Counter Drugs Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Over-the-Counter Drugs Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Over-the-Counter Drugs Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Over-the-Counter Drugs Market Size by Regions
  10. 3.3.1 North America Over-the-Counter Drugs Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Over-the-Counter Drugs Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Over-the-Counter Drugs Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Over-the-Counter Drugs Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Over-the-Counter Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Over-the-Counter Drugs Industry Trends
  2. 4.2 Over-the-Counter Drugs Industry Drivers
  3. 4.3 Over-the-Counter Drugs Industry Opportunities and Challenges
  4. 4.4 Over-the-Counter Drugs Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Over-the-Counter Drugs Revenue (2021-2026)
  2. 5.2 Global Over-the-Counter Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Over-the-Counter Drugs Key Company Headquarters & Area Served
  4. 5.4 Global Over-the-Counter Drugs Company, Product Type & Application
  5. 5.5 Global Over-the-Counter Drugs Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Over-the-Counter Drugs Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Over-the-Counter Drugs Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Over-the-Counter Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries
  2. 6.1.1 Teva Pharmaceutical Industries Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Over-the-Counter Drugs Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Over-the-Counter Drugs Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Over-the-Counter Drugs Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Over-the-Counter Drugs Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Over-the-Counter Drugs Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Over-the-Counter Drugs Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Over-the-Counter Drugs Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Over-the-Counter Drugs Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Merck
  26. 6.5.1 Merck Company Information
  27. 6.5.2 Merck Business Overview
  28. 6.5.3 Merck Over-the-Counter Drugs Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Merck Over-the-Counter Drugs Product Portfolio
  30. 6.5.5 Merck Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Over-the-Counter Drugs Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Over-the-Counter Drugs Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Over-the-Counter Drugs Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Over-the-Counter Drugs Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Bayer
  44. 6.8.1 Bayer Company Information
  45. 6.8.2 Bayer Business Overview
  46. 6.8.3 Bayer Over-the-Counter Drugs Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Bayer Over-the-Counter Drugs Product Portfolio
  48. 6.8.5 Bayer Recent Developments
  49. 6.9 Sun Pharmaceutical Industries
  50. 6.9.1 Sun Pharmaceutical Industries Company Information
  51. 6.9.2 Sun Pharmaceutical Industries Business Overview
  52. 6.9.3 Sun Pharmaceutical Industries Over-the-Counter Drugs Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Sun Pharmaceutical Industries Over-the-Counter Drugs Product Portfolio
  54. 6.9.5 Sun Pharmaceutical Industries Recent Developments
  55. 6.10 Glenmark Pharmaceuticals
  56. 6.10.1 Glenmark Pharmaceuticals Company Information
  57. 6.10.2 Glenmark Pharmaceuticals Business Overview
  58. 6.10.3 Glenmark Pharmaceuticals Over-the-Counter Drugs Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Glenmark Pharmaceuticals Over-the-Counter Drugs Product Portfolio
  60. 6.10.5 Glenmark Pharmaceuticals Recent Developments
  61. 6.11 Cipla
  62. 6.11.1 Cipla Company Information
  63. 6.11.2 Cipla Business Overview
  64. 6.11.3 Cipla Over-the-Counter Drugs Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Cipla Over-the-Counter Drugs Product Portfolio
  66. 6.11.5 Cipla Recent Developments
  67. 6.12 Boehringer Ingelheim
  68. 6.12.1 Boehringer Ingelheim Company Information
  69. 6.12.2 Boehringer Ingelheim Business Overview
  70. 6.12.3 Boehringer Ingelheim Over-the-Counter Drugs Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Boehringer Ingelheim Over-the-Counter Drugs Product Portfolio
  72. 6.12.5 Boehringer Ingelheim Recent Developments
  73. 6.13 Alkem Laboratories
  74. 6.13.1 Alkem Laboratories Company Information
  75. 6.13.2 Alkem Laboratories Business Overview
  76. 6.13.3 Alkem Laboratories Over-the-Counter Drugs Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Alkem Laboratories Over-the-Counter Drugs Product Portfolio
  78. 6.13.5 Alkem Laboratories Recent Developments
7 North America
  1. 7.1 North America Over-the-Counter Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Over-the-Counter Drugs Market Size by Country (2021-2026)
  3. 7.3 North America Over-the-Counter Drugs Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Over-the-Counter Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Over-the-Counter Drugs Market Size by Country (2021-2026)
  3. 8.3 Europe Over-the-Counter Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Over-the-Counter Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Over-the-Counter Drugs Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Over-the-Counter Drugs Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Over-the-Counter Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Over-the-Counter Drugs Market Size by Country (2021-2026)
  3. 10.3 South America Over-the-Counter Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Over-the-Counter Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Over-the-Counter Drugs Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Over-the-Counter Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research